mTOR, but not GSK-3β or JNK, was the tyrosine kinase receptor located in downstream of AKT, and, in Ubenimex-treated MDR GC cells, mTOR bound to P-gp and MRP1 proteins. Here, AKT1 is linked to gastric cancer.